Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Different Approaches Of Allogeneic Stem Cell Transplantation For Acute Leukemias In Suzhou (China) Lead To Similar Outcome Compared With European Group For Blood and Marrow Transplantation (EBMT) Results: A Pair-Matched Analysis

Jia Chen, MD, Yin Lu, Myriam Labopin, MD, Depei Wu, MD, Mohamad Mohty, MD, PhD, Norbert C. Gorin, MD, PhD

Blood (2013) 122 (21): 2131.

https://doi.org/10.1182/blood.V122.21.2131.2131

Published: 2013

Journal Articles

Haploidentical Mismatched Allogeneic Versus Autologous Hematopoietic STEM CELL Transplantation in Adult Patients with ACUTE Myeloid Leukemia (AML) in First Complete Remission (CR1): A Pair-Matched Analysis From the Acute Leukemia Working Party of EBMT.

Norbert C. Gorin, MD, PhD, Myriam Labopin, Fabio Ciceri, MD, Andrea Velardi, MD, PhD, Stella Santarone, MD, William Arcese, MD, Mohamad Mohty, MD PhD

Blood (2012) 120 (21): 3093.

https://doi.org/10.1182/blood.V120.21.3093.3093

Published: 2012

Journal Articles

Association of Deferasirox and Vitamin D Promotes Cell Differentiation and Improves Overall Survival in Acute Myeloid Leukemia (AML) Elderly Patients After Demethylating Agents Failure: A Retrospective Case Control Study

Etienne Paubelle, Felipe Suarez, MD, PhD, Florence Zylbersztejn, Celine Callens, PharmD PhD, Michael Dussiot, Marc Benhamou, Françoise Isnard, MD, Marie T Rubio, MD, PhD, Gandhi Damaj, Norbert C. Gorin, MD, PhD, Jean-Pierre Marolleau, MD, PhD, Ivan Cruz Moura, PhD, Olivier Hermine

Blood (2012) 120 (21): 3622.

https://doi.org/10.1182/blood.V120.21.3622.3622

Published: 2012

Journal Articles

Comparison of MRI and 18F-FDG PET for Evaluation of the Response to Treatment of Patients Diagnosed with Multiple Myeloma: A Prospective Clinical Study

Catherine Phan, Veronique gaura Schmidt, Chaima Kellil, Souhila Ikhlef, Philippe Moreau, MD, Anne Miquel, Clement Pradel, Norbert C. Gorin, MD, PhD, jean Yves Devaux, Yves Menu, Laurent Garderet, MD

Blood (2012) 120 (21): 4004.

https://doi.org/10.1182/blood.V120.21.4004.4004

Published: 2012

Journal Articles

Long-Term Follow-up of Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Acute Myeloid Leukemia (AML): A Survey of 3567 Patients From the Acute Leukemia Working Party of the EBMT.

Tomasz Czerw, MD, Myriam Labopin, Norbert C. Gorin, MD, PhD, Sebastian Giebel, MD, Didier Blaise, MD, Giovanna Meloni, MD, Arnaud Pigneux, MD, PhD, Alberto Bosi, MD, Hendrik Veelken, MD PhD, Felicetto Ferrara, MD, Nicolaas Schaap, MD, PhD, Michele Baccarani, MD, Mohamad Mohty

Blood (2012) 120 (21): 3112.

https://doi.org/10.1182/blood.V120.21.3112.3112

Published: 2012

Journal Articles

Interest of the Association Azacitidine-Lenalidomide As Front Line Therapy in High-Risk Myelodysplasia (MDS) or Acute Myeloid Leukemia (AML) with Complex Karyotype

Elodie Scherman, Sandra Malak, MD, Christine Perot, MD, Norbert C. Gorin, MD, PhD, Marie T Rubio, MD, PhD, Françoise Isnard, MD

Blood (2011) 118 (21): 5035.

https://doi.org/10.1182/blood.V118.21.5035.5035

Published: 2011

Journal Articles

The Presence of An Internal Tandem Duplicate of FlT3 Receptor (ITD) Is An Unfavorable Prognostic Factor on the Outcome of Adult Patients with Acute Myeloid Leukemia (AML) Autografted in First Remission (CR1) Only in the Absence of An NPM1 Mutation,

Norbert C. Gorin, MD, PhD, Myriam Labopin, MD, MS, Giovanna Meloni, MD, Arnaud Pigneux, MD, Jordi Esteve, MD, Miguel A. Sanz, MD, PhD, Alberto Bosi, William Arcese, MD, Giuseppe Milone, MD, PhD, Emmanuelle Polge, Mohamad Mohty

Blood (2011) 118 (21): 4139.

https://doi.org/10.1182/blood.V118.21.4139.4139

Published: 2011

Journal Articles

Impact of the Presence of An Internal Tandem Duplicate of FlT3 Receptor (ITD) on the Outcome of Adult Patients with Acute Myelocytic Leukemia (AML) Autografted In First Remission (CR1)Norbert-Claude Gorin, Myriam Labopin, Jordi Esteve, and Mohamad Mohty, on Behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

Norbert C. Gorin, MD, PhD, Myriam Labopin, MD, Jordi Esteve, MD, Mohamad Mohty

Blood (2010) 116 (21): 3556.

https://doi.org/10.1182/blood.V116.21.3556.3556

Published: 2010

Journal Articles

Bortezomib(Velcade®)-Thalidomide-Dexamethasone (VTD) Is Superior to Thalidomide-Dexamethasone (TD) In Patients with Multiple Myeloma (MM) Progressing or Relapsing After Autologous Transplantation

Blood (2010) 116 (21): 3043.

https://doi.org/10.1182/blood.V116.21.3043.3043

Published: 2010

Journal Articles

Identical Outcome Following Autologous or Allogeneic Genoidentical Hematopoietic Stem Cell Transplantation in First Complete Remission for Good Risk Acute Myelocytic Leukemia Carrying INV 16 or t(8;21): A Retrospective Comparison from the Acute Leukemia Working Party (ALWP) of the European Cooperative Group for Blood and Marrow Transplantation (EBMT).

Norbert C. Gorin, MD, PhD, Myriam Labopin, MD, Francesco Frassoni, MD, Emmanuelle Polge, Vanderson Rocha, MD, PhD, Acute Leukemia Working Party of EBMT

Blood (2007) 110 (11): 605.

https://doi.org/10.1182/blood.V110.11.605.605

Published: 2007

Journal Articles

Results of Non Myeloablative Geno-Identical Transplants in Adults with AML: Influence of the Doses of Peripheral Stem Cells Infused (on Behalf of the Acute Leukemia Working Party of EBMT).

Norbert C. Gorin, MD, PhD, Myriam Labopin, MD, Francesco Frassoni, MD, Vanderson Rocha, MD

Blood (2005) 106 (11): 5409.

https://doi.org/10.1182/blood.V106.11.5409.5409

Published: 2005

NARROW

Different Approaches Of Allogeneic Stem Cell Transplantation For Acute Leukemias In Suzhou (China) Lead To Similar Outcome Compared With European Group For Blood and Marrow Transplantation (EBMT) Results: A Pair-Matched Analysis

Haploidentical Mismatched Allogeneic Versus Autologous Hematopoietic STEM CELL Transplantation in Adult Patients with ACUTE Myeloid Leukemia (AML) in First Complete Remission (CR1): A Pair-Matched Analysis From the Acute Leukemia Working Party of EBMT.

Association of Deferasirox and Vitamin D Promotes Cell Differentiation and Improves Overall Survival in Acute Myeloid Leukemia (AML) Elderly Patients After Demethylating Agents Failure: A Retrospective Case Control Study

Comparison of MRI and 18F-FDG PET for Evaluation of the Response to Treatment of Patients Diagnosed with Multiple Myeloma: A Prospective Clinical Study

Long-Term Follow-up of Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Acute Myeloid Leukemia (AML): A Survey of 3567 Patients From the Acute Leukemia Working Party of the EBMT.

Interest of the Association Azacitidine-Lenalidomide As Front Line Therapy in High-Risk Myelodysplasia (MDS) or Acute Myeloid Leukemia (AML) with Complex Karyotype

The Presence of An Internal Tandem Duplicate of FlT3 Receptor (ITD) Is An Unfavorable Prognostic Factor on the Outcome of Adult Patients with Acute Myeloid Leukemia (AML) Autografted in First Remission (CR1) Only in the Absence of An NPM1 Mutation,

Bortezomib(Velcade®)-Thalidomide-Dexamethasone (VTD) Is Superior to Thalidomide-Dexamethasone (TD) In Patients with Multiple Myeloma (MM) Progressing or Relapsing After Autologous Transplantation

Results of Non Myeloablative Geno-Identical Transplants in Adults with AML: Influence of the Doses of Peripheral Stem Cells Infused (on Behalf of the Acute Leukemia Working Party of EBMT).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only